How we got here.

On a Mission to Maximize Global Health

Our Vision

PERSOWN, Inc. is our founding company.  We evolved from our efforts to commercialize a professors invention of an instant saliva test for Covid spike proteins. We saw a greater need for low-cost point of care diagnostics and training.  PERSOWN Connect, Inc. was incorporated to focus a long view on leveraging existing technologies to expand access to affordable care services for a billion underserved families. Our sustainable platform is based on a capital efficient business model.  We are integrating text-based payments and micro financing to efficiently provide state of the art tools to healthcare organizations in developing countries.  

Our vision is a world in which no one suffers or dies from treatable communicable disease, everyone receives swift, effective care when unavoidable illness arises, and good health supported by good technology allows humankind to live each day to the fullest.

Our Values make the difference

  • Drive Innovation
  • Foster Empathy
  • Commitment to Collaboration
  • Ensure Accessibility
  • Support Sustainability
  • People First

 

the story from our founder and chairman

Back when we started in 2019, we quickly got to see firsthand how life was rapidly changing due to the COVID-19 Pandemic in 2020.  I quickly realized the best way to navigate the pandemic successfully was through instant point of care testing. The testing had to be easy yet extremely accurate, it had to deliver results fast, it had to be affordable, and if we were going to stop the spread, it had to be able to detect very low levels of the virus in patient saliva.  In fact, it had to be able to detect the virus before the patient was symptomatic and before they were highly contagious.

Early in our search for a diagnostic solution that would meet those requirements, we found that only an electrochemistry-based approach could satisfy all the criteria. So, we assembled a world-class team of electrochemists and began to review prior applications of electrochemistry to medical diagnostics. We studied what had worked and what had not, many with serious limitations.

Persown<br />

What we found was that we could apply the advances in electronics that were driven by the rapid evolution of the smartphone and bluetooth to efficiently eliminate the previously experienced limitations. The result of our efforts was a strong IP supported portfolio that makes the foundation of a powerful diagnostic platform.

(Note: the graphic is a functional proof of concept device with bluetooth connection to our smartphone app using a disposable saliva test strip inserted in the bottom.)

It quickly became apparent that we could use this foundation to not only change the course of the current pandemic, but also to provide early detection of heart attacks, concussion, tuberculosis, various cancers and dozens of other conditions.  We learned that nearly every protein in your blood can be found in your saliva!!

We also began developing a software platform to integrate existing diagnostic testing with electronic patient records into highly secure, low cost open source resources globally for instant access. This was a powerful realization, coupled with the discovery that 75% of physicians globally do not have access to state-of-the-art diagnostic capabilities, fueled the expansion of our vision.  We learned that in developing countries there is a fundamental lack of basic medical technology particularly in rural communities and smaller villages.  

Given the efficiency and scalability of software, we expanded our architecture to link historical and episodic patient data to the SAS Viya software for “continuous care analytics” initially for reducing SEPSIS deaths. Most patient data today is kept in proprietary silos rather than patient-centric.

We decided to create PERSOWN Analytics, Inc. to focus on linking hospital and third-party patient data to continuously monitor patients across their coverage of episodic care. Beyond sepsis, we will be able to run dozens of acute and chronic care models offering continuous monitoring of patients beyond the hospital improving care performance and substantial reduction in healthcare costs for all stakeholders.

,As we grow, we will leverage the advances enabled by the global deployment of affordable satellite communications with smart phones, to link patients to physicians to treatments – enabling the complete healthcare cycle, resulting in positive transformation of health outcomes around the globe.

Our approach to this complete cycle from diagnostics through positive outcome, evolves around the patient – enabling you as a patient to one day have control of all your medical records enabling proactive care with early detection and treatment anytime, anyplace.

We plan to build profitable companies for our customers: existing global health organizations in developing countries around technology, diagnostics and training that offer affordable healthcare with global access.  We are bringing state-of-the-art health care with affordable text-based payments, coupled with 24/7 telehealth AI guided Certified Medical Technician access through mobile phone satellite/internet connections anywhere in the world.

We invite you to join our mission with the confidence that your investment will make the world a better place.

Billy Meadow
Founder and Chairman

 

OUR PARTNERS

acorn
UF Research
acorn
acorn
acorn
burstIQ

DISCOVER HOW TO BECOME AN INTEGRATION PARTNER

We invite you to discuss how we can partner to build a dynamic consortium of governments, NGOs, health foundations, micro-financing institutions, insurance companies, product distributors, pharmacies and technology innovators.

Language